Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

We recently compiled a list of the 30 Most Important AI Stocks According to BlackRock. In this article, we are going to take ...

That includes the MiniMed 780G automated insulin delivery (AID) system, cleared by the U.S. Food and Drug Administration (FDA) in 2023. This helped the Diabetes segment's organic sales increase by ...

The recent boost is partly due to Medtronic's newest insulin pump, the MiniMed 780G, which earned clearance in the U.S. in April 2023. One of this device's biggest perks is that it features an ...

Medtronic's MiniMed 670G - the closest thing yet to an artificial pancreas - has been launched in the US. The so-called 'hybrid closed-loop' system comprises a blood glucose sensor ...

The firm faced an FDA warning letter for Its MiniMed 600 insulin pump, which I highlighted in an earlier article. This, combined with competition from pod-based insulin delivery with no pumps or ...

Selbyville, Delaware, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Sensor Patch market is estimated to reach USD 60 billion by 2032, as ...

Pharmac – Te Pātaka Whaioranga has decided to fund continuous glucose monitors (CGMs), insulin pumps, and insulin pump consumables for people with type 1 diabetes from 1 October 2024.

The headline numbers from Medtronic highlight a solid start to its fiscal 2025. For the company's first quarter, adjusted ...

Artificial intelligence has been the buzzword around Wall Street for many months but a recent selloff in the technology sector has ignited fears of an AI bubble.

Moreover, I've completed a comparative analysis of the system relative to Medtronic's (MDT) MiniMed system and Tandem Diabetes (TNDM) tX2 with the control-IQ technology (Figure 3). The question is ...